ALEX LEY ROJO: Open Payments
NPI 1588360002 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$578 in 15 payments from 7 companies in 2025. Trend: 2023 $140 · 2024 $752 · 2025 $578
Food & beverage: $578
| Company | Payments | Amount |
|---|---|---|
| USWM, LLC | 1 | $125 |
| Novo Nordisk Inc | 1 | $119 |
| Amgen Inc. | 5 | $106 |
| Alexion Pharmaceuticals, Inc. | 1 | $98 |
| Lilly USA, LLC | 4 | $83 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| ABBVIE INC. | 1 | $15 |
Products named: IWILFIN, Ozempic, Repatha, MOUNJARO, Kerendia, KRYSTEXXA, JARDIANCE, OTEZLA.
Industry payments across NV — which companies pay providers there.
